Jubilant Ingrevia Share Price

    NSE
    704.60
    +3.95 (0.57%)
    JUBLINGREA • 20 Aug, 2025 | 03:29 PM
    Buy
    with MTF at2.81xleverage

    1Y Annualised Return

    11.32%

    3Y Annualised Return

    14.00%

    The current prices are delayed, login or Open Demat Account for live prices.

    Jubilant Ingrevia Stock Performance

    1W Return0.54
    1Y Return10.47
    Today's Low695.1
    Prev. Close700.65
    Mkt Cap (Cr.)11,160.03
    1M Return-15.55
    3Y Return44.54
    52-Week High885
    Open700.95
    PE Ratio38.49
    6M Return2.96
    Today's High708.3
    52-Week Low535.2
    Face Value1

    Jubilant Ingrevia Company background

    Founded in: 2019
    Managing director: Mr. Deepak Jain
    Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh. The name of the Company was changed from Jubilant LSI Limited to Jubilant Ingrevia Limited on October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, costeffective and conforming to excellent quality standards. The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. The Group has four flagships companies listed on Indian Stock Exchanges Jubilant Ingrevia Limited, Jubilant Pharmova Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. The Companys stateoftheart manufacturing facilities across India offer a range of products and solutions that are innovative, costeffective and quality driven. It established itself as a single point solution for CDMO services for global Pharmaceutical and Agrochemical companies. It is at present across the value chain like Route design, Process Development, Process Optimisation, Scaleup and Commercial Manufacturing of Advance Intermediates for Pharma and Agro and Actives for Agrochemicals. It is a leading supplier of Ethanol to Oil Marketing Companies (OMCs) for Ethanol Blending Programme (EBP) among standalone distilleries in India. The Company is engaged in manufacturing and supply of speciality intermediates, nutrition health solutions and life science chemicals through five manufacturing facilities in India. It offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the Company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The business focuses on three core segments Speciality Chemicals, Nutrition and Health Solutions and Life Science Chemicals. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3, Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of Vitamin B3 and Indias largest manufacturer of Vitamin B4. The Company is a Partner of Choice for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand Phytoshield. The Life Science Ingredients (LSI) business of Jubilant Pharmova Limited was demerged into the Company, (Jubilant Ingrevia Limited) through the Scheme of Amalgamation effective from February 1, 2021. Pursuant to Composite Scheme of Arrangement, 5 subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from the said date.During FY 202223, the Company acquired 37.98% of equity share capital of Mister Veg Foods Private Limited (MVFPL) effective March 16, 2023. It commissioned the 25,000 TPA New Acetic Anhydride Plant in Bharuch, Gujarat.The Company launched new products by introducing the foodgrade Choline Chloride and Choline Bitartrate in FY24. Further, a new agrochemical plant at SEZ Bharuch commissioned in FY 2024. The Phase II of Diketene Derivatives with the addition of 2000 TPA for multiple products was commissioned. A multipurpose Agro Actives Intermediate plant in Bharuch and a Diketene Derivatives plant in Gajraula commissioned in FY24.New plants commissioned for food and cosmeticgrade niacinamide/niacin facility and Diketene derivatives plants in FY 2025.

    Jubilant Ingrevia Financial Highlights


    Jubilant Ingrevia reported a Q1 FY 2025-26 revenue of ₹1037.95 crore, up 1.1% YoY, with net profit increased 37.4% to ₹75.16 crore. For the full year FY20252026, revenue reached ₹4215.43 crore and profit touched at ₹251.19 crore. As of Jun '25, Jubilant Ingrevia’s market capitalisation stood at ₹11,160.03 crores. Shareholding as of Jun '25 shows promoters holding 45.2%, with FIIs at 7%, DIIs at 21.8%, and public at 25.3%.

    As of 20 Aug, 2025, Jubilant Ingrevia share price is ₹702. The stock opened at ₹701 and had closed at ₹700.6 the previous day. During today’s trading session, Jubilant Ingrevia share price moved between ₹695.10 and ₹708.30, with an average price for the day of ₹701.70. Over the last 52 weeks, the stock has recorded a low of ₹535.20 and a high of ₹885.00. In terms of performance, Jubilant Ingrevia share price has increased by 3.4% over the past six months and has increased by 11.32% over the last year.
    Read More
    Jubilant Ingrevia SIP Return Calculator

    Over the past

    1 year
    3 years
    Total Investment of ₹65,00,000
    Would have become ₹68,83,595 (+5.90%)
    Daily SIP of 25,000 would have become 68,83,595 in 1 year with a gain of 3,83,595 (+5.90%)
    View details of Market Depth

    Jubilant Ingrevia Fundamental

    Market Cap (in crs)

    11,160.03

    Face Value

    1

    Turnover (in lacs)

    750.09

    Key Metrics

    Qtr Change %
    31.16% Gain from 52W Low
    0.5
    Dividend yield 1yr %
    Above industry Median
    0.7

    Jubilant Ingrevia Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Jubilant Ingrevia Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    1037.95 Cr
    1051.26 Cr
    1056.77 Cr
    1045.24 Cr
    1024.34 Cr
    Jubilant Ingrevia Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    4215.43 Cr
    4171.1 Cr
    4806.06 Cr
    4980.85 Cr
    686.73 Cr
    Jubilant Ingrevia Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    75.16 Cr
    74.02 Cr
    69.37 Cr
    59 Cr
    48.66 Cr
    Jubilant Ingrevia Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    251.19 Cr
    182.87 Cr
    307.53 Cr
    476.76 Cr
    54.36 Cr
    -0.17 Cr

    Jubilant Ingrevia Result Highlights

    • Jubilant Ingrevia Ltd reported a 3.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 1.5%.

    • Its expenses for the quarter were down by 8.1% QoQ and 1.9% YoY.

    • The net profit increased 156.8% QoQ and increased 54.1% YoY.

    • The earnings per share (EPS) of Jubilant Ingrevia Ltd stood at 4.8 during Q1 FY 2025-26.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Jubilant Ingrevia Shareholding Pattern

    Promoter
    45.2%
    Foreign Institutions
    7%
    Mutual Funds
    19.6%
    Domestic Institutions
    21.8%
    Public
    25.3%
    Promoter
    51.5%
    Foreign Institutions
    7.1%
    Mutual Funds
    14.1%
    Domestic Institutions
    15.9%
    Public
    24.8%
    Promoter
    51.5%
    Foreign Institutions
    6.9%
    Mutual Funds
    13.9%
    Domestic Institutions
    16%
    Public
    24.9%
    Promoter
    51.5%
    Foreign Institutions
    7.2%
    Mutual Funds
    12.7%
    Domestic Institutions
    15.5%
    Public
    25.1%
    Promoter
    51.5%
    Foreign Institutions
    6.6%
    Mutual Funds
    10.6%
    Domestic Institutions
    14%
    Public
    27.1%
    Promoter
    51.5%
    Foreign Institutions
    6.6%
    Mutual Funds
    10.2%
    Domestic Institutions
    13.6%
    Public
    27.5%

    Jubilant Ingrevia Technical Analysis

    Moving Averages Analysis
    704.60
    Current Price
    Bullish Moving Averages
    1
    Bearish Moving Averages
    15
    5Day EMA
    703.50
    10Day EMA
    714.10
    12Day EMA
    719.20
    20Day EMA
    735.30
    26Day EMA
    742.00
    50Day EMA
    745.70
    100Day EMA
    733.50
    200Day EMA
    709.30
    5Day SMA
    701.00
    10Day SMA
    706.00
    20Day SMA
    748.40
    30Day SMA
    771.60
    50Day SMA
    760.10
    100Day SMA
    719.80
    150Day SMA
    707.00
    200Day SMA
    721.60
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    171541 Rs
    387977 Rs
    Week Rs
    88981 Rs
    208887 Rs
    Month Rs
    145705 Rs
    352654 Rs
    706.25
    Pivot
    Resistance
    First Resistance
    714.40
    Second Resistance
    728.15
    Third Resistance
    736.30
    Support
    First Support
    692.50
    Second support
    684.35
    Third Support
    670.60
    Relative Strength Index
    34.07
    Money Flow Index
    21.89
    MACD
    -22.76
    MACD Signal
    -16.67
    Average True Range
    25.22
    Average Directional Index
    21.95
    Rate of Change (21)
    -15.71
    Rate of Change (125)
    6.22
    Name
    Holding Percent
    DSP SMALL CAP FUND
    8.86
    KOTAK SMALL CAP FUND
    2.8
    AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND A/C AXIS SMALL CAP FUND
    2.04
    HDFC MUTUAL FUND - HDFC MANUFACTURING FUND
    1.7
    BANDHAN INNOVATION FUND
    1.16
    EDELWEISS TRUSTEESHIP CO LTD AC- EDELWEISS MF AC-EDELWEISS SMALL CAP FUND
    1.07
    FRANKLIN INDIA SMALLER COMPANIES FUND
    1

    Jubilant Ingrevia Latest News

    19 AUG 2025 | Tuesday

    Jubilant Ingrevia Ltd - 543271 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    13 AUG 2025 | Wednesday

    Jubilant Ingrevia Ltd - 543271 - Intimation Of Record Date For Maturity Of Commercial Papers

    13 AUG 2025 | Wednesday

    Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Credit Rating

    View More

    Jubilant Ingrevia Share Price FAQs

    Jubilant Ingrevia share price is ₹704.60 in NSE and ₹705.55 in BSE as on 20/8/2025.

    Jubilant Ingrevia share price in the past 1-year return was 10.47. The Jubilant Ingrevia share hit a 1-year low of Rs. 535.2 and a 1-year high of Rs. 885.

    The market cap of Jubilant Ingrevia is Rs. 11160.03 Cr. as of 20/8/2025.

    The PE ratios of Jubilant Ingrevia is 38.49 as of 20/8/2025.

    The PB ratios of Jubilant Ingrevia is 4.56 as of 20/8/2025

    The Mutual Fund Shareholding in Jubilant Ingrevia was 19.57% at the end of 20/8/2025.

    You can easily buy Jubilant Ingrevia shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Jubilant Ingrevia share price is ₹885 and ₹535.2 as of 20/8/2025.

    The earnings per share (EPS) of Jubilant Ingrevia stood at 4.8 during Q1 FY 2025-26.

    Please be aware that Jubilant Ingrevia stock prices are subject to continuous fluctuations due to various factors.

    Open Demat Account
    +91 -

    Popular Stocks
    59.81
    +0.22 (+0.37%)
    126.70
    -0.10 (-0.08%)
    689.15
    -11.10 (-1.59%)
    2,384.80
    -3.60 (-0.15%)
    148.76
    -0.15 (-0.10%)
    330.90
    +3.15 (+0.96%)
    161.87
    +2.64 (+1.66%)
    325.90
    +4.45 (+1.38%)
    371.70
    -8.35 (-2.20%)
    390.45
    +1.30 (+0.33%)
    Top Gainers
    1,496.20
    +56.20 (+3.90%)
    3,098.60
    +82.40 (+2.73%)
    2,669.80
    +65.00 (+2.50%)
    1,190.30
    +28.90 (+2.49%)
    342.00
    +6.95 (+2.07%)
    Top Losers
    371.85
    -8.20 (-2.16%)
    887.80
    -14.50 (-1.61%)
    616.30
    -10.05 (-1.60%)
    689.60
    -10.65 (-1.52%)
    778.20
    -7.30 (-0.93%)
    Open Demat Account
    +91 -